{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for clindamycin root_notes_note in Note (approximate match)
Status:
Possibly Marketed Outside US
Source:
21 CFR 348
(2014)
Source URL:
First approved in 2014
Source:
21 CFR 348
Source URL:
Class:
MIXTURE
Status:
Possibly Marketed Outside US
Source:
21 CFR 333A
(2014)
Source URL:
First approved in 2014
Source:
21 CFR 333A
Source URL:
Class:
MIXTURE
Status:
Possibly Marketed Outside US
Source:
21 CFR 352
(2012)
Source URL:
First approved in 2012
Source:
21 CFR 352
Source URL:
Class:
MIXTURE
Status:
Possibly Marketed Outside US
Source:
Zithranol by Elorac Inc.
(2012)
Source URL:
First approved in 2008
Source:
21 CFR 333
Source URL:
Class:
MIXTURE
Status:
Possibly Marketed Outside US
Source:
21 CFR 333C
(2005)
Source URL:
First approved in 2002
Source:
21 CFR 358H
Source URL:
Class:
MIXTURE
Status:
Possibly Marketed Outside US
Source:
ANDA040246
(2000)
Source URL:
First approved in 2000
Source:
ANDA040246
Source URL:
Class:
MIXTURE
Status:
Possibly Marketed Outside US
Source:
ANDA205606
(1989)
Source URL:
First approved in 1989
Source:
ANDA205606
Source URL:
Class:
MIXTURE
Status:
Possibly Marketed Outside US
Source:
Derma Lip Plumper Balm by Pella Pharmaceuticals Co. ltd
(2014)
Source URL:
First approved in 1981
Source:
ANDA086414
Source URL:
Class:
MIXTURE
Status:
Investigational
Source:
Allergy. May 2006;61(5):622-8.: Not Applicable Human clinical trial Completed N/A
Source URL:
Class:
POLYMER
Status:
Other
Class:
POLYMER
